Correction

First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAFV600-mutant advanced melanoma patients: a propensity-matched survival analysis (Mar, 10.1038/s41416-022-01772-z, 2022)

BRITISH JOURNAL OF CANCER (2022)

卷 126, 期 9, 页码 1362-1362

DOI: 10.1038/s41416-022-01772-z

Oncology

A correction to the paper has been published.

A Correction to this paper has been published: https://doi.org/10.1038/s41416-021-01312-1

点击您的名字以认领此论文并将其添加到您的个人资料中。